Prefilled Syringe Testing to ISO 11040

ISO 11040 and ISO 7886 both address syringes but cover fundamentally different device types and use cases.

ISO 7886-1 applies to sterile hypodermic syringes — devices that are supplied empty and filled at the point of care. Testing under ISO 7886-1 focuses on the mechanical properties of the syringe itself, primarily the quality of the plunger stopper seal and the break loose and glide forces required to operate the plunger.

ISO 11040, by contrast, applies to prefilled syringes that are filled with a drug or compound during manufacturing and supplied ready for use. While some test methods overlap — such as break loose and extrusion force — ISO 11040 places additional emphasis on combination product performance, container closure integrity, and the interaction between the syringe and its contents over the full shelf life of the device, reflecting the added complexity of a product that must maintain drug integrity from the point of manufacture through to administration.

ISO 11040 specifies requirements and test methods for glass and plastic prefilled syringes and their subcomponents. It is used by manufacturers in the pharmaceutical and medical device industries to verify that syringes and their components meet dimensional, material, and functional performance requirements before reaching end users.

ISO 11040 is composed of 8 parts. Parts 1–3 cover subcomponents of dental anesthetic cartridges. Parts 4–6 address subcomponents of prefilled syringes, including glass barrels, plastic barrels, and plunger stoppers. Part 7 covers packaging for pre-sterilized fill and finish applications. Part 8 specifies requirements and test methods for the finished prefilled syringe as a complete device.

ISO 11040-8 evaluates the finished prefilled syringe as a combination product rather than assessing individual components. Tests include break loose and extrusion force, needle penetration force, liquid leakage, burst resistance, and — as of the 2026 revision — administration time. The standard applies to syringes used for both manual injections and within needle-based injection systems such as autoinjectors.

The 2026 revision introduces four key changes: an expanded definition of intended use that must inform all test procedures; the codification of Break Loose and Extrusion Force testing as a standalone Annex A with explicit guidance on data capture rates and speed parameters; consolidation of Liquid Leakage and Burst Resistance testing into a new Annex C; and a new Administration Time test method in Annex D, which is particularly relevant for biologics and high-viscosity drug formulations. For most labs, transitioning from the 2016 version will primarily require software method updates rather than hardware changes.

Intended use is a foundational concept in ISO 11040-8, and the 2026 revision significantly expanded its role. Factors such as the route of delivery, patient population, clinical vs. home-use setting, and criticality of administration can all directly influence which test methods apply and how parameters such as test speed should be set. Documenting intended use thoroughly is essential for justifying test methodology decisions during design verification.

ISO 11040 testing typically requires a universal testing system, appropriate software, and a range of fixtures to accommodate the different test methods within the standard. A modular fixture that can be reconfigured across test types is recommended for labs testing to multiple parts of the standard. Biaxial testing capability is also required for device closure evaluation, such as luer lock removal torque testing.

Yes. Certain ISO 11040 test procedures — particularly removal torque testing of rigid tip caps per Annex G.5 — are well suited to automation using a collaborative robot (cobot). Automation reduces operator influence, improves specimen alignment repeatability, and increases overall lab throughput, making it particularly valuable for high-volume testing environments.

Break loose force is the initial force required to start moving the plunger stopper within the syringe barrel, while extrusion force is the sustained force required to continue dispensing the contents. Both are critical functional performance metrics — excessive force can make a device difficult or impossible to use in a clinical setting. These tests are addressed in ISO 11040-8 Annex A and are among the most commonly performed evaluations in prefilled syringe testing.

Needle penetration force testing measures the force required for a syringe needle to penetrate a defined membrane or stopper material. It is an important indicator of usability and patient experience, particularly for self-injection devices. This test is among the functional performance evaluations covered under ISO 11040-8.